Explore more publications!
Today in Law

Latest News

Support for Mesothelioma Patients: Q&A With Oncology Social Worker Lindsey Rotnem

Support for Mesothelioma Patients: Q&A With Oncology Social Worker Lindsey Rotnem

Fancy dress morning raises funds and awareness of mesothelioma

Fancy dress morning raises funds and awareness of mesothelioma

How Mesothelioma Hope Helped the Fengarinas Family Get Support and Compensation

How Mesothelioma Hope Helped the Fengarinas Family Get Support and Compensation

Understanding Mesothelioma and Its Hidden Risks 

Understanding Mesothelioma and Its Hidden Risks 

Workers and Families Affected by Mesothelioma or Asbestos Lung Cancer May Qualify to File a Lawsuit and Receive Compensation

Workers and Families Affected by Mesothelioma or Asbestos Lung Cancer May Qualify to File a Lawsuit and Receive Compensation

Spotting Red Flags to Avoid Mesothelioma Lawsuit Scams

Spotting Red Flags to Avoid Mesothelioma Lawsuit Scams

Trends and Costs in Older Malignant Pleural Mesothelioma Patients

Trends and Costs in Older Malignant Pleural Mesothelioma Patients

Therapeutic Frontiers in Malignant Mesothelioma Management

Therapeutic Frontiers in Malignant Mesothelioma Management

What To Do If You Find Asbestos Under Your Tile

What To Do If You Find Asbestos Under Your Tile

From Diagnosis to Treatment and Care: Understanding Mesothelioma

From Diagnosis to Treatment and Care: Understanding Mesothelioma

Top 5 States for Asbestos Exposure: Mesothelioma Cases by State

Top 5 States for Asbestos Exposure: Mesothelioma Cases by State

The Financial Impact of Chronic Illness: Mesothelioma as a Case Study

The Financial Impact of Chronic Illness: Mesothelioma as a Case Study

New HSENI advertising campaign aimed at reducing over 300 work-related deaths

New HSENI advertising campaign aimed at reducing over 300 work-related deaths

Dutch daycares remove decorative craft sand after asbestos alert

Dutch daycares remove decorative craft sand after asbestos alert

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board

Your Guide to Improving Mesothelioma Quality of Life

Your Guide to Improving Mesothelioma Quality of Life

New campaign aims to help reduce deaths from work-related illnesses

New campaign aims to help reduce deaths from work-related illnesses

How Mesothelioma Is Linked to Asbestos Exposure

How Mesothelioma Is Linked to Asbestos Exposure

Family asking for 'even the smallest pieces of information' after Gedling man's death

Family asking for 'even the smallest pieces of information' after Gedling man's death

3rd Circ. Remands J&J Unit's Libel Suit Over Talc Study

3rd Circ. Remands J&J Unit's Libel Suit Over Talc Study

Today in Law

Press Releases

Mesothelioma Victims Center Urges a Welder or Skilled Trades Worker with Mesothelioma or Asbestos Exposure Lung Cancer to Call for Direct Access to the USA's Top Lawyers for Compensation-Not a Law Firm Call Center
US Navy Veterans Mesothelioma & Lung Cancer Advocate Now Offers Direct Access to The Nation's Top Lawyers for a Navy Ship-Submarine or Shipyard Worker with Mesothelioma or Lung Cancer to Ensure a Top Compensation Result
Mesothelioma Compensation Center Is Offering a Power Plant Worker with Mesothelioma or Asbestos Exposure Lung Cancer on the Spot Access to the Best Lawyers in the USA-Not a Law Firm's Call Center--Get Top Compensation
Mesothelioma Victims Center Appeals to a Plumber or Skilled Trades Worker with Mesothelioma or Asbestos Exposure Lung Cancer to Call for Direct Access to The Nation's Best Compensation Lawyers-Don't Play Lawyer Roulette
Mesothelioma Compensation Center Urges a Chemical Plant or Oil Refinery Worker with Mesothelioma to Call Them for Direst Access to The Nation's Top Lawyers for Compensation Results-Not A Broker
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
Mesothelioma Victims Center Now Offers to Make Certain a Plumber or a Skilled Trades Worker with Mesothelioma Anywhere in the USA is Talking with the Nation's Top Mesothelioma Attorneys-Not a Law Firm Call Center
Mesothelioma Compensation Centers Appeals to a Refinery or Chemical Plant Worker with Mesothelioma or Lung Cancer to Call Them for Direct Access to The Nation's Top Lawyers-Not A Marketing Law Firm Call Center
US Navy Veterans Mesothelioma & Lung Cancer Advocate Urges a Navy Submarine Veteran with Mesothelioma or Lung Cancer to Call Them for Direct Access to The Nation’s Top Attorneys-Not a Marketing Law Firm Call Center
Mesothelioma Compensation Center and Lung Cancer Asbestos Victims Center Now Offer to Help Former Power Plant Workers with Mesothelioma or Asbestos Lung Cancer to Ensure People Like This Get a Top Compensation Result
US Navy Veterans Mesothelioma and Lung Cancer Advocates Offer an Honest Service Nationwide to Ensure a Navy Submarine Veteran with Mesothelioma or Lung Cancer Talks Directly with the Nation's Top Lawyers-Not a Broker
US Navy Veterans Mesothelioma & Lung Cancer Advocate Join Forces to Make Certain a Veteran with These Cancers Gets Immediate Access to The Nation's Top Lawyers for Superior Compensation-Not A Law Firm Middleman
Lung Cancer Asbestos Victims Center and the Mesothelioma Victims Center Now Offer a Skilled Trades Worker Who Now Has Mesothelioma or Asbestos Lung Cancer Direct Access to the Nation's Top Lawyers-No Middlemen Law Firms
US Navy Veterans Lung Cancer Advocate Teams Up with The US Navy Veterans Mesothelioma Advocate to Make Sure a Navy Veteran with Mesothelioma or Lung Cancer Have Direct Access to the Nation’s Top Lawyers-Not Middlemen
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
Levin Papantonio Announces Jury Awards $20 Million Verdict in Talc Mesothelioma Case Casaretto Estate v. Johnson & Johnson
AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions